Retinoids: Versatile biological response modifiers of vascular smooth muscle phenotype

Circulation Research

Volumn 87, Issue 5, 2000, Pages 355-362

  Miano, Joseph M ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Development; Differentiation; Growth; Neointima; Receptor; Retinoic acid

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; RETINOID;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; HUMAN; INTIMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034283415     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.5.355     Document Type: Review

References (112)

1. Regulation of differentiation of vascular smooth muscle cells
2. Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall
3. Differentiated properties and proliferation of arterial smooth muscle cells in culture
4. Pathobiology of intimal hyperplasia
5. The steroid and thyroid hormone receptor superfamily
6. The protective effects of estrogen on the cardiovascular system
7. 3 modulates growth of vascular smooth muscle cells
8. Peroxisome proliferator-activated receptor-α activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
9. Retinoids and cell growth in the cardiovascular system
10. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
11. Tissue changes following deprivation of fat-soluble A vitamin
12. A choroid plexus papilloma in an elasmobranch (Squalus acanthias)
13. β-Carotene: An unusual type of lipid antioxidant
14. β-Carotene: A miss for epidemiology
15. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease
16. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease
17. Randomized trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
18. β-Carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study
19. Alcohol, vitamin A, and β-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity
20. Activity of 'vitamin A-acid' in the rat
21. Retinoids in embryonal development
22. Retinoids: The biochemical and molecular basis of vitamin A and retinoid action
23. The induction of differentiation in teratocarcinoma stem cells by retinoic acid
24. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
25. Applications for retinoids in cancer therapy
26. Retinoids and chemoprevention: Clinical and basic studies
27. All-trans retinoic acid in acute promyelocytic leukemia
28. The plasma transport and metabolism of retinoic acid in the rat
29. Plasma delivery of retinoic acid to tissues in the rat
30. Clinical pharmacology of all-trans retinoic acid
31. Interactions of retinoid binding proteins and enzymes in retinoid metabolism
32. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
33. Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia
34. A decade of molecular biology of retinoic acid receptors
35. Retinoic acid receptors and cellular retinoid binding proteins, I: A systematic study of their differential pattern of transcription during mouse organogenesis
36. Retinoic acid receptors and cellular retinoid binding proteins, II: Their differential pattern of transcription during early morphogenesis in mouse embryos
37. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
38. Developmental expression of murine retinoid X receptor (RXR) genes
39. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells
40. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development
41. Cellular biology and biochemistry of the retinoids
42. Retinoid receptors in health and disease: Co-regulators and the chromatin connection
43. The language of covalent histone modifications
44. Phosphorylation of the retinoic acid receptor-α by protein kinase A
45. The biological activity of retinoic acid in the domestic fowl and the effects of vitamin A deficiency on the chick embryo
46. Effects of retinoid deficiency on the development of the heart and vascular system of the quail embryo
47. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
48. Induction of avascular yolk sac due to reduction of basic fibroblast growth factor by retinoic acid in mice
49. Retinoic acid embryopathy
50. RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis
51. Genetic analysis of RXRα developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis
52. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
53. RXRγ null mice are apparently normal and compound RXRα(+/-)/RXRβ(-/-)/RXRyγ(-/-) mutant mice are viable
54. Mesectoderm is a major target of retinoic acid action
55. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells
56. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence
57. Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions
58. Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus
59. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells
60. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-α
61. Cloning and characterization of the murine PKC α promoter: Identification of a retinoic acid response element
62. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics
63. Preferential differentiation of P19 mouse embryonal carcinoma cells into smooth muscle cells: Use of retinoic acid and antisense against the central nervous system-specific POU transcription factor Brn-2
64. 7 integrin receptor in differentiated smooth muscle cells
65. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: A retinoic acid and db-cAMP in vitro differentiation model
66. Angiotensin II-induced stimulation of smooth muscle α-actin expression by serum response factor and the homeodomain transcription factor MHox
67. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells
68. Effect of retinoic acid on contractile competence of vascular smooth muscle
69. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells
70. Retinoic acid enhances the proliferation of smooth muscle cells
71. Retinoic acid regulation of renal tubular epithelial and vascular smooth muscle cell function
72. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells
73. Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor-α exert synergistic antiproliferative effects on human coronary artery smooth muscle cells
74. Inhibition of proliferation of chondrocytes by specific receptors in response to retinoids
75. Cultured porcine coronary artery smooth muscle cells: A new model with advanced differentiation
76. Retinol influences contractile function and exerts an anti-proliferative effect on vascular smooth muscle cells through an endothelium-dependent mechanism
77. Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimal smooth muscle cells
78. RAR γ agonists inhibit proliferation of vascular smooth muscle cells
79. Modulation of endothelial cell shape and growth by retinoids
80. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo
81. Differences in metabolism and isomerization of all-trans-retinoic acid and 9-cisretinoic acid between human endothelial cells and hepatocytes
82. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury
83. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent signaling pathway
84. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury
85. All-trans retinoic acid reduces intimal thickening after balloon angioplasty in atherosclerotic rabbits
86. All-transretinoic acid attenuates neointima formation with acceleration of reendothelialization in balloon-injured rat aorta
87. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow
88. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line
89. 1 during repair of arterial injury
90. Smooth muscle cell immediate early gene and growth factor activation follows vascular injury: A putative in vivo mechanism for autocrine growth
91. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
92. Retinoylation of proteins in leukemia, embryonal carcinoma, and normal kidney cells lines: Differences associated with differential responses to retinoic acid
93. All-trans-retinoic add limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: A favorable effect on vessel remodeling
94. Downregulation of angiotensin II type I receptor by all-trans retinoic acid in vascular smooth muscle cells
95. Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-α
96. Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic acid: Absence of effects on apolipoprotein A-II gene expression
97. Retinoic acid-responsive enhancers located 3' of the Hox A and Hox B homeobox gene clusters: Functional analysis
98. Transcriptional activation of the human p21(WAF/CIP1) gene by retinoic acid receptor: Correlation with retinoid induction of U937 cell differentiation
99. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene
100. Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at-7 kilobases
101. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter
102. Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells
103. The late retinoic acid induction of laminin B1 gene transcription involves RAR binding to the responsive element
104. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells
105. Retinoic acid and triiodothronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells
106. Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines
107. Retinoic acid is a negative regulator of AP-1-responsive genes
108. Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity
109. Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene
110. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation
111. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids
112. Retinoid-regulated expression of bcl-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells